{"id":"W2520297993","doi":"10.1002/jcph.828","title":"Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"Bayer","keywords":"Tolerability; Medicine; Placebo; Agonist; Ejection fraction; Partial agonist; Heart failure; Adenosine; Anesthesia; Cardiology; Heart rate; Internal medicine; Blood pressure; Adverse effect; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001284528,0.0001371835,0.0009401063,0.00005717038,0.00003625814,0.000002779662,0.00008010039,0.0001193931,0.0002713121],"category_scores_gemma":[0.0002032154,0.00006215698,0.0001626678,0.000111532,0.000408856,0.00008834404,0.00005491109,0.0003948474,0.000004717452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001105266,"about_ca_system_score_gemma":0.0002855777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002585015,"about_ca_topic_score_gemma":0.00002789323,"domain_scores_codex":[0.9978387,0.000395292,0.00115012,0.0001510871,0.000244409,0.0002203735],"domain_scores_gemma":[0.9980261,0.0008620006,0.0005572498,0.000144938,0.0002227077,0.0001869683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03367262,0.001399824,0.9504349,0.00003221114,0.0005544266,0.00001952,0.00006076461,0.00002087013,0.002744312,0.000006296164,0.004600408,0.006453804],"study_design_scores_gemma":[0.03411194,0.005294632,0.9449229,0.0001415792,0.0005402333,0.00007167802,0.000008438128,0.00001169354,0.001185512,0.00001251125,0.01362252,0.00007640113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848807,0.0002069566,0.00005511007,0.01380959,0.0006242254,0.000361254,0.00003643059,0.000004153499,0.00002158975],"genre_scores_gemma":[0.9984143,0.0002461583,0.0002295926,0.0003879078,0.0006697941,0.000001986887,0.000002576775,0.00001284315,0.00003479969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01353365,"threshold_uncertainty_score":0.2970678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02495858391310683,"score_gpt":0.3546411885409498,"score_spread":0.3296826046278429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}